Urban Health Today Editors

Urban Health Today

Researchers recently presented <a href="https://ashpublications.org/blood/article/138/Supplement%201/400/478197/Inadequate-Sars-Cov-2-Vaccine-Effectiveness-in">data</a> indicating that the effectiveness of vaccines against SARS-CoV-2 may be reduced in patients with multiple myeloma (MM) or monoclonal gammopathy of undetermined significance (MGUS).The study included 3,661 patients treated for MM at the national Veterans Affairs (VA) system in each of the prior 3 years; 818 vaccinated patients were matched with 818 who were not. In addition, 11,323 patients with MGUS were included; 4,798 who were vaccinated were matched with 4,798 who were not. In total, there was 11,232 patients, with a mean age of 73 years.Among patients with MM, the estimated effectiveness of the vaccine was 9.7% from dose 1 to the end of the study, 12.6% from dose 2 to the end of the study, and 5.6% from 14 days after dose 2 to end of study.Effectiveness improved in patients with MGUS but was still somewhat lower than in general population. In this group, the effectiveness was 28.4% from dose 1 to end of study, 34.1% from dose 2 to end of study, and 27.2% from 14 days after dose 2 to end of study. Among patients with MM who were vaccinated but not treated in the last 6 months, 2.6% of patients had breakthrough SARS-CoV-2 infection. The rate of breakthrough infection was 5.2% among patients with more recent treatment.The researchers said that although vaccination is an effective strategy for preventing SARS-CoV-2, the effectiveness may be reduced in patients with MM, likely due to coexisting immunosuppression.Future studies need to evaluate disease state, type/timing of therapy, and determine the role of post-vaccination serologies and booster vaccination.

Lou Portero

Women with Autoimmune Conditions Face Double the Risk of Heart Disease Death Compared to Men

Autoimmune Disease in Women

Rebecca Araujo

AI-Driven Insulin Support: Are These Tools Ready for Diabetes Care?

Diabetes

Heart Rate Complexity May Predict Cognitive Decline in Older Adults

Alzheimer's & Dementia

Latest News

SARS-CoV-2 Vaccinations Less Effective in Patients With Multiple Myeloma

COVID

Researchers recently presented data indicating that the effectiveness of vaccines against SARS-CoV-2 may be reduced in ...

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Cancer

Gastroenterology

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Public Health

Autoimmune Disease

Infectious Diseases

Obesity

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe